BridgeBio have demonstrably improved this course of a new treatment for ATTR-CM, employing the compound. Initial trial data indicates significant improvements for patients affected by the severe illness. This emphasis represents the company’s dedication to treating significant healthcare requirements in the heart arena. Attruby: BridgeBio's Nove